A more comprehensive screen
Human cell microarray technology has long been the leading tool for discovering primary receptors and assessing potential off-target binding against expressed human proteins. Over a decade of continual development has ensured that the Retrogenix library is of the highest quality. Initially representing only plasma membrane monomers, the Retrogenix library now, uniquely, includes cell surface heterodimers as well as secreted proteins that have been identified as key off-targets for screening through our close collaborations with toxicology teams at leading pharmaceutical companies. Our rigorous bioinformatics approach ensures that miscategorised proteins are always excluded from our library, safeguarding the specificity of our results and providing clients with the confidence that real targets will discovered and won’t be masked by a raft of false positives.